Dengue Epidemiology in Pediatric Populations in Malaysia
Malaysia demonstrates persistently high dengue seroprevalence reaching 79% overall in urban populations, with pediatric seroprevalence increasing progressively from 22.7% in children under 5 years to over 90% by age 70, indicating that most Malaysian children will be infected during childhood or adolescence 1.
Seroprevalence Data
The most recent population-based study from 2018 in Petaling district (urban Malaysia) provides the clearest picture 1:
- Overall seroprevalence: 79.0% (95% CI: 75.2-82.4%)
- Age-specific pediatric rates:
- <5 years: 22.7% (95% CI: 9.6-45.0%)
- 5-9 years: Data shows progressive increase with odds ratio of 13.43 compared to <5 years
- 10-19 years: Historically identified as peak incidence age group 2
- ≥60 years: 94.9% (cumulative lifetime exposure)
The odds of seropositivity increase dramatically with each age bracket, reaching OR of 384.77 for those ≥60 years compared to children under 5 1. This demonstrates continuous, high-level transmission throughout childhood and adolescence.
Urban vs Rural Patterns
A critical finding from the 2016 multi-survey analysis shows that dengue seroprevalence has equalized between urban and rural areas by 2008, both reaching similarly high levels 3. Previously, rural areas had lower pediatric seroprevalence, but this gap has closed, meaning all Malaysian children are now at comparable risk regardless of location 3.
Incidence and Severe Disease Rates
Historical data from the 1973 epidemic and subsequent surveillance reveals 2, 4:
- Peak age groups for severe disease: 5-9 years and 10-19 years with mean morbidity rate of 4.9 cases per 100,000
- Hemorrhagic manifestations: 68.7% of hospitalized cases
- Dengue shock syndrome: 18.1% of cases
- Case fatality rate: 6.4% overall, but highest in 0-4 years age group
- Males more affected for incidence, but females have higher case fatality rates 2
Recent 2023 data from Pulau Pinang shows dramatic increases, with cases rising from 1,621 in 2022 to 7,343 in 2023, indicating ongoing epidemic activity 5.
Key Clinical Implications
All four dengue serotypes circulate in Malaysia, with DEN-2 and DEN-3 historically predominant during epidemics 2, 6. The molecular epidemiology from 2015-2021 shows high viral diversity with repetitive genotype turnover, maintaining population heterogeneity 6.
Critical risk factors for outbreaks include 5:
- Aedes Index ≥1% (OR: 1.35)
- Priority Locality 1 areas (previous outbreak zones)
- Delayed time from notification to investigation (OR: 2.40)
Vaccination Considerations
Given the 79% overall seroprevalence and progressive age-related increase, most Malaysian children will have prior dengue exposure by adolescence 1. However, no Malaysian region meets the WHO threshold of 80% seroprevalence by age 9 for CYD-TDV vaccination, and very few reach the 60% threshold for TAK-003 7. This creates a complex vaccination landscape where individual serological testing becomes essential to identify dengue-naive children at risk for antibody-dependent enhancement 8.
The persistently high transmission means that by age 70, cumulative seroprevalence exceeds 90%, translating to 16.5 million Malaysians (55% of total population) infected by 2013 3. This endemic stability has persisted since 2001 in urban areas and equalized in rural areas by 2008 3.